Bottom line
SWISX vs IQLT: the short answer
SWISX (Schwab International Index Fund) and IQLT (iShares MSCI Intl Quality Factor ETF) share a meaningful slice of their top holdings — about 52% by weight.
But SWISX is far broader, holding 697 positions to 320 for IQLT, so beyond the top names it adds exposure IQLT doesn't have.
SWISX is cheaper at 0.06% vs 0.3% — a difference of $24 a year per $10,000 invested.
Over five years, SWISX returned +9.0% a year vs +5.5% for IQLT (reporting dates differ).
Updated Nov 19, 2026
SWISX vs IQLT side by side
| SWISX | IQLT | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Schwab | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 0.06% | 0.3% |
| Annual cost per $10k | $6 | $30 |
| 10-yr cost on $10k (prospectus) | $77 | $381 |
| Max front load | — | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +31.6% | +1.7% |
| 5-yr return (annualized) | +9.0% | +5.5% |
| 10-yr return (annualized) | +8.3% | +6.4% |
| Best quarter | +18.2% | +17.8% |
| Worst quarter | −23.2% | −19.5% |
| Net assets (fund) | $13.6B | $13.8B |
| Number of holdings | 697 | 320 |
| Portfolio turnover | 1% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SWISX | IQLT | Difference |
|---|---|---|---|
| 2024 | +3.5% | +1.7% | +1.8% |
| 2023 | +18.2% | +18.5% | −0.3% |
| 2022 | −14.3% | −15.1% | +0.8% |
| 2021 | +11.3% | +12.8% | −1.5% |
| 2020 | +8.1% | +13.1% | −5.0% |
| 2019 | +21.9% | +27.8% | −6.0% |
| 2018 | −13.3% | −10.9% | −2.5% |
| 2017 | +25.3% | +24.1% | +1.2% |
| 2016 | +1.1% | +0.6% | +0.5% |
Source: Fund prospectus bar charts
Holdings overlap
14 of SWISX's top 25 holdings also appear in IQLT's top 25.
| Holding | SWISX | IQLT |
|---|---|---|
| ASML Holding NV | 2.58% | 5.42% |
| Roche Holding AG | 1.48% | 2.20% |
| AstraZeneca PLC | 1.34% | 1.68% |
| Novartis AG | 1.30% | 1.78% |
| Nestle SA | 1.14% | 1.81% |
| Shell PLC | 1.03% | 1.59% |
| Novo Nordisk A/S | 0.89% | 1.12% |
| Allianz SE | 0.79% | 2.68% |
| LVMH Moet Hennessy Louis Vuitton SE | 0.75% | 1.01% |
| Schneider Electric SE | 0.73% | 1.43% |
| Unilever PLC | 0.69% | 1.34% |
| TotalEnergies SE | 0.67% | 1.32% |
| Iberdrola SA | 0.66% | 1.32% |
| Rolls-Royce Holdings PLC | 0.65% | 1.50% |
Source: SEC Form N-PORT
SWISX top 10
- ASML Holding NV — 2.58%
- Roche Holding AG — 1.48%
- HSBC Holdings PLC — 1.41%
- AstraZeneca PLC — 1.34%
- Novartis AG — 1.30%
- Nestle SA — 1.14%
- Siemens AG — 1.06%
- Shell PLC — 1.03%
- Toyota Motor Corp — 0.99%
- Sap Se — 0.96%
IQLT top 10
- ASML Holding N.V. — 5.42%
- Allianz SE — 2.68%
- Roche Holding AG — 2.20%
- ABB Ltd — 1.95%
- Zurich Insurance Group AG — 1.83%
- Nestle S.A. — 1.81%
- Novartis AG — 1.78%
- Astrazeneca Plc — 1.68%
- Advantest Corporation — 1.65%
- Shell Plc — 1.59%
FAQ
What is the difference between SWISX and IQLT?
Which is cheaper, SWISX or IQLT?
Should I own both SWISX and IQLT?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.